|
|
|
| Confirmatory testing of 120 positive HIV antibody screening samples in Lanxi City |
| XU Yahua1, WU Bin2
|
1. Department of Microbiology, Lanxi Center for Disease Control and Prevention, Lanxi, Zhejiang 321100, China;
2. Jinhua Center for Disease Control and Prevention, Jinhua, Zhejiang 321002, China |
|
|
|
|
Abstract Objective To analyze the confirmatory test results of 120 positive HIV antibody screening samples in Lanxi City, Zhejiang Province, so as to provide insights into AIDS detection and control. Methods Western blotting confirmatory assay was performed on 120 positive HIV antibody samples from HIV screening laboratories in Lanxi City from 2020 to 2022. The confirmatory test results were determined according to the “National Technical Guidelines for AIDS Testing (2020 revision)” and “Diagnosis for HIV/AIDS” (WS 293-2019), and the positive rate of confirmatory test and band distribution were analyzed. Results Among 120 positive HIV antibody screening samples, there were 100 HIV-1 antibody positive samples (83.33%) as revealed by Western blotting confirmatory assay, 6 HIV antibody negative samples (5.00%), and 14 HIV-1 indeterminate tests (11.67%). There were 72 men and 28 men tested positive for HIV-1 antibody, with a male to female ratio of 2.57∶1, and there were 88 patients at ages of 20 to 59 years (88.00%), with the highest frequency of gp160, gp120 and p24 bands (100.00%). The most common Western blotting band pattern was p24 among HIV-1 indeterminate tests (78.57%). Among all HIV-1 indeterminate Western blotting tests, 6 cases were tested positive for HIV-1 antibody (gp160+p24) and 8 cases tested negative for HIV antibody during the follow-up period. Conclusions The prevalence of HIV-1 antibody was 83.33% in 120 positive HIV antibody screening samples in Lanxi City. The three most common Western blotting band patterns were gp160, gp120 and p24. The follow-up requires to be reinforced in HIV-1 indeterminate Western blotting tests for early identification and early intervention.
|
|
Received: 20 February 2023
Revised: 10 April 2023
Published: 17 June 2023
|
|
|
|
|
|
[1] 张伟宏,纳玮,张晓萍.526例HIV抗体初筛阳性标本复核确证结果分析[J].宁夏医学杂志,2017,39(4):370-372.
[2] 中国疾病预防控制中心.全国艾滋病检测技术规范(2020年修订版)[S].北京:中国疾病预防控制中心,2020.
[3] 中华人民共和国国家卫生健康委员会.艾滋病和艾滋病病毒感染诊断标准:WS 293—2019[S].2019.
[4] 陈旭富,宋鹏霞,吕磊,等.衢州市HIV抗体初筛阳性样本确证结果分析[J].预防医学,2018,30(4):398-399.
[5] 吴斌. 金华市2014—2018年艾滋病疫情分析[J].中国农村卫生事业管理,2020,40(5):377-380.
[6] 王亚男,胡清海,张博雯,等.2006—2016年某综合性医院确诊HIV阳性患者特征分析[J].中国公共卫生,2018,34(6):914-916.
[7] 程栋,徐璐,薛秀娟,等.2017—2019年河南省新乡市疑似HIV感染样本确证试验结果分析[J].河南预防医学杂志,2022,33(1):84-86.
[8] 周丽敏,王希峰,梁赢,等.2018年—2021年北京市大兴区疑似HIV感染样本确证实验结果分析[J].中国卫生检验杂志,2022,32(23):2862-2864,2869.
[9] 王海燕. 艾滋病检测中HIV抗体不确定结果的分析[J].世界最新医学信息文摘,2017,17(57):130.
[10] 魏彬,丰姝,罗娅,等.2013年HIV抗体免疫印迹试验确证不确定结果分析[J].现代预防医学,2015,42(15):2788-2792.
[11] 尤佳女,陈兵,许珂,等.疑似HIV感染者样本抗体筛查蛋白印迹试验及核酸检测结果分析[J].中国艾滋病性病,2021,27(7):741-744.
[12] 张荣秋,李莉,张建梅,等.2013—2017年厦门市HIV抗体蛋白印迹实验检测结果分析[J].现代预防医学,2018,45(21):3981-3984. |
|
|
|
